690269-84-2Relevant academic research and scientific papers
Structure-Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase
Eldrup, Anne B.,Allerson, Charles R.,Bennett, C. Frank,Bera, Sanjib,Bhat, Balkrishen,Bhat, Neelima,Bosserman, Michele R.,Brooks, Jennifer,Burlein, Christine,Carroll, Steven S.,Cook, P. Dan,Getty, Krista L.,MacCoss, Malcolm,McMasters, Daniel R.,Olsen, David B.,Prakash, Thazha P.,Prhavc, Marija,Song, Quanlai,Tomassini, Joanne E.,Xia, Jie
, p. 2283 - 2295 (2007/10/03)
As part of a continued effort to identify inhibitors of hepatitis C viral (HCV) replication, we report here the synthesis and evaluation of a series of nucleoside analogues and their corresponding triphosphates. Nucleosides were evaluated for their ability to inhibit HCV RNA replication in a cell-based, subgenomic replicon system, while nucleoside triphosphates were evaluated for their ability to inhibit in vitro RNA synthesis mediated by the HCV RNA-dependent RNA polymerase, NS5B. 2′-C-Methyladenosine and 2′-C-methylguanosine were identified as potent inhibitors of HCV RNA replication, and the corresponding triphosphates were found to be potent inhibitors of HCV NS5B-mediated RNA synthesis. The data generated in the cell-based assay demonstrated a fairly stringent structure- activity relationship around the active nucleosides. Increase in steric bulk beyond methyl on C2, change in the stereo- or regiochemistry of the methyl substituent, or change of identity of the heterobase beyond that of the endogenous adenine or guanine was found to lead to loss of inhibitory activity. The results highlight the importance of the ribo configuration 2′- and 3′-hydroxy pharmacophores for inhibition of HCV RNA replication in the cell-based assay and demonstrate that inclusion of the 2′ -C-methylribonucleoside pharmacophore leads to increased resistance to adenosine deaminase and purine nucleoside phosphorylase mediated metabolism.
